Comparative bioavailability of commercially available mefenamic acid tablets

A study of the comparative bioavailability of three commercially available mefenamic acid tablets [500 mg] was carried out on six healthy human male volunteers using Latin square design of experiments. Variations observed in the values of different bioavailability parameters could hr attributed to the factors affecting the in-vivo dissolution of a tablet dosage form